RKT — Rocketdna Income Statement
0.000.00%
- AU$8.85m
- AU$6.41m
- AU$7.24m
- 41
- 60
- 43
- 47
Annual income statement for Rocketdna, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.37 | 4.58 | 5.73 | 6.14 | 7.24 |
Cost of Revenue | |||||
Gross Profit | 1.97 | 2.43 | 2.8 | 3.13 | 3.64 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.35 | 6.34 | 8.08 | 7.89 | 8.78 |
Operating Profit | 0.022 | -1.75 | -2.34 | -1.75 | -1.54 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.025 | -1.74 | -2.34 | -1.79 | -1.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.061 | -1.71 | -2.42 | -1.86 | -1.93 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.184 | -3.62 | -1.92 | -1.77 | -1.92 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.184 | -3.62 | -1.92 | -1.77 | -1.92 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.003 | -0.005 | -0.003 | -0.003 |